By Dr Nan Hu

Journal articles

Lingam R; Hiscock H; Khano S; Murphy JB; Wheeler K; Tuttle A; Forrester B; Preddy J; McMillan F; Bullock S; Hodgins M; Crespo C; Hu N; Forrester M; Tickell D; Hibbert P; Brydon M; Dalziel K; Pierce K; Sawrikar V; Chondros P; Sanci L, 2026, 'Strengthening Care for Rural Children (SC4RC): study protocol for a stepped-wedge translational trial of an integrated general practitioner–paediatrician model of primary care in regional Victoria and New South Wales', Trials, 27, http://dx.doi.org/10.1186/s13063-025-09307-6

Scherpereel A; Mansfield AS; Grossi F; Popat S; Baas P; Nowak AK; Tsao AS; Fujimoto N; Peters S; Aragon YB; Talbot T; Kowalski D; Kaplan MA; Cardona AF; Soomro R; Hu N; Lee A; Ip V; Hung Y-H; Zalcman G, 2026, 'Reply to: “Beyond Response Rates: Interpreting Long-Term Benefit in CheckMate 743” and “Beyond Statistical Significance: Methodologic Fragility and Censoring Bias in the 5-Year Update of CheckMate 743”', Journal of Clinical Oncology, 44, pp. 2651 - 2652, http://dx.doi.org/10.1200/jco-26-01153

Nishio M; Hayashi H; Goto Y; Ikeda S; Yokoyama T; Tanaka H; Tambo Y; Hotta K; Fukuhara T; Daga H; Masubuchi K; Aoyama T; Tschaika M; Hu N; Mizutani H, 2026, 'Nivolumab plus ipilimumab-based treatment in Japanese patients with metastatic non-small cell lung cancer and tumor PD-L1 < 1%: a pooled analysis', International Journal of Clinical Oncology, pp. 1 - 12, http://dx.doi.org/10.1007/s10147-026-03116-w

Scherpereel A; Baas P; Nowak AK; Tsao AS; Fujimoto N; Peters S; Mansfield AS; Popat S; Aragon YB; Talbot T; Grossi F; Kowalski D; Kaplan MA; Cardona AF; Soomro R; Hu N; Lee A; Ip V; Hung Y-H; Zalcman G, 2026, 'Erratum: Five-Year Clinical Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Unresectable Pleural Mesothelioma in CheckMate 743', Journal of Clinical Oncology, 44, pp. 1852 - 1852, http://dx.doi.org/10.1200/jco-26-01289

Hii AWW; Khan JR; Paul KK; Chan M; Hu N; McMullan B; Britton PN; Bartlett AW; Kandasamy R; Owens L; Prentice B; Jaffe A; Homaira N, 2026, 'In-Hospital Complications of Influenza A and B Among Hospitalized Australian Children in the Post-COVID Era', Clinical Respiratory Journal, 20, http://dx.doi.org/10.1111/crj.70217

Hodgins M; Ostojic K; Edwards K; Lawson K; Hu N; Lyle K; Jubelin M; Arora A; Baird K; Dadich A; Eapen V; Henry A; Hopwood N; Kohlhoff J; O’Loughlin G; Lingam R; Rogers H; Raman S; Rimes T; Woolfenden S; Group OBOTFC, 2026, 'The Barriers and Enablers to Implementing Child and Family Health Hubs for Migrant Families', International Journal of Integrated Care, 26, pp. 16, http://dx.doi.org/10.5334/ijic.9847

Khan JR; Hu N; Lingam R, 2026, 'Expanding the predictive horizon in developmental coordination disorder screening: Promise and gaps', Developmental Medicine and Child Neurology, 68, pp. 740, http://dx.doi.org/10.1111/dmcn.70035

Scherpereel A; Baas P; Nowak AK; Tsao AS; Fujimoto N; Peters S; Mansfield AS; Popat S; Aragon YB; Talbot T; Grossi F; Kowalski D; Kaplan MA; Cardona AF; Soomro R; Hu N; Lee A; Ip V; Hung Y-H; Zalcman G, 2026, 'Five-Year Clinical Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Unresectable Pleural Mesothelioma in CheckMate 743', Journal of Clinical Oncology, 44, pp. 742 - 749, http://dx.doi.org/10.1200/jco-25-01328

Islam MA; Chan M; Khan JR; Hu N; McMullan B; Britton PN; Bartlett AW; Kandasamy R; Prentice B; Jaffe A; Homaira N, 2026, 'Human Metapneumovirus-associated Acute Lower Respiratory Hospitalizations in Children <5 Years Pre-, During and Post-COVID-19 Pandemic: A Multicenter Study', Pediatric Infectious Disease Journal, Publish Ahead of Print, http://dx.doi.org/10.1097/INF.0000000000005138

He WQ; Dey C; Li C; Hu N; Perkes I; Kan H; Lingam R; Sara G; Jay O; Nassar N, 2026, 'Heat Exposure and Hospital Admissions for Mental Health Disorders in a Changing Climate', Journal of the American Academy of Child and Adolescent Psychiatry, http://dx.doi.org/10.1016/j.jaac.2026.05.001

Morris TM; Hiscock H; Wheeler K; Miller C; Hu N; Shire SH; Crespo-Gonzalez C; Bullock S; Taylor N; Boyle D; Sanci L; Lawson K; Adams L; Peacock K; Hodgins M; Christie A; Lingam R, 2026, 'Strengthening Care for Children Using a Virtual Integrated General Practitioner–Pediatrician Model of Primary Care (SUSTAIN): Protocol for a Stepped Wedge Cluster Randomized Controlled Trial', Jmir Research Protocols, 15, http://dx.doi.org/10.2196/69728

de Groot A; Mackle R; Gray M; Chan M; Hodgins M; Hu N; Angell B; Campbell N; Owens L; Fletcher J; McCrossin T; Piper S; Du H; Haggie S; Doyle AK; Woolfenden S; Gould B; Ward F; Jaffe A; Homaira N; Lingam R; Crespo-Gonzalez C, 2026, 'Understanding how personalized pediatric asthma information and support addresses rural families’ unmet needs', Journal of Rural Health, 42, http://dx.doi.org/10.1111/jrh.70125

Sangro B; Decaens T; Galle PR; Kudo M; Qin S; Da Fonseca LG; Karachiwala H; Park J-W; Gane E; Pinter M; Tai DW; Santoro A; Pizarro G; Schenker M; He AR; Hu N; Jiménez MJ; Matteotti R; Blum SI; Yau T, 2026, '26 - EVALUACIÓN GLOBAL DE LA CALIDAD DE VIDA RELACIONADA CON SALUD (CVRS) Y VALORACIÓN DE LA EFICACIA EN PACIENTES QUE INTERRUMPIERON EL TRATAMIENTO DEBIDO A ACONTECIMIENTOS ADVERSOS RELACIONADOS CON EL TRATAMIENTO (AARTS): RESULTADOS DEL ESTUDIO CHECKMATE 9DW', Gastroenterología y Hepatología, 49, pp. 113237, http://dx.doi.org/10.1016/s0210-5705(26)00453-x

Sangro B; Decaens T; Galle PR; Qin S; da Fonseca LG; Karachiwala H; Park J-W; Gane E; Pinter M; Tai DW; Santoro A; Pizarro G; Schenker M; He AR; Hu N; Jiménez MJ; Yau T, 2026, '27 - NIVOLUMAB MÁS IPILIMUMAB (NIVO + IPI) FRENTE A LENVATINIB O SORAFENIB (LEN/SOR) COMO TRATAMIENTO DE PRIMERA LÍNEA (1L) EN CARCINOMA HEPATOCELULAR IRRESECABLE (CHCI): EFICACIA EN PACIENTES CON MAL PRONÓSTICO Y SEGURIDAD HEPÁTICA EN LA POBLACIÓN GLOBAL DEL ESTUDIO CHECKMATE 9DW', Gastroenterología y Hepatología, 49, pp. 113238, http://dx.doi.org/10.1016/s0210-5705(26)00454-1

Badin FB; Carbone DP; Ciuleanu T-E; Cobo-Dols M; Schenker M; Menezes J; Richardet E; Felip E; Vidal OJ; Alexandru A; Mizutani H; Reinmuth N; Lu S; Reck M; John T; Scherpereel A; de Marchi P; Aoyama T; Sathyanarayana P; Grootendorst DJ; Hu N; Ip V; Hung Y-H; Paz-Ares L, 2026, 'PP01.56: Final, 6-Year Outcomes with First-Line (1L) Nivolumab Plus Ipilimumab Plus Chemotherapy (N+I+C) in Patients with Metastatic Non-Small Cell Lung Cancer (mNSCLC) from CheckMate 9LA', Journal of Thoracic Oncology, 21, pp. 103799, http://dx.doi.org/10.1016/j.jtho.2026.103799

Rashid MM; Hu N; Chan M; khan JR; Jaffe A; Homaira N, 2025, 'Risk Factors for Asthma Readmission Among Australian Children- A Population-Based Cohort Study', Pediatric Pulmonology, 60, http://dx.doi.org/10.1002/ppul.71433

Hu N; Gelaw YA; Katz I; Fernandez E; Falster K; Hanly M; Newton BJ; Stephensen J; Hotton P; Zwi K; Lingam R, 2025, 'Corrigendum to “Developmental trajectories of socio-emotional outcomes of children and young people in out-of-home care – Insights from data of Pathways of Care Longitudinal Study (POCLS)” [Child Abuse & Neglect Volume 149, 2024, 149:106196] (Child Abuse & Neglect (2024) 149, (S0145213423001771), (10.1016/j.chiabu.2023.106196))', Child Abuse and Neglect, 169, http://dx.doi.org/10.1016/j.chiabu.2025.107661

Mackle R; Crespo-Gonzalez C; Gray M; Chan M; Hodgins M; Hu N; Angell B; Campbell N; Owens L; Fletcher J; McCrossin T; Piper S; Du H; Haggie S; Doyle AK; Woolfenden S; Gould B; Ward F; Lingam R; Homaira N; Jaffé A, 2025, 'Implementing enhanced paediatric asthma care in rural Australia: Qualitative insights from healthcare professionals', Respiratory Medicine, 249, http://dx.doi.org/10.1016/j.rmed.2025.108444

Ostojic K; Hu N; Hodgins M; Lawson KD; Jubelin M; Rogers HJ; Hopwood N; Henry A; Kaplan C; Kohlhoff J; Baird K; Dadich A; Szanto T; Lingam R; Raman S; Eapen V; Rimes T; Woolfenden S; Adams J; Arora A; Aspery W; De Vroome M; Edwards K; Gale M; Grace R; Green M; Goodger B; Harris-Roxas B; Hayen A; Hua M; Jagers D; Johns A; Lawson K; Lyle K; Matha D; O’Loughlin G; Rodgers K; Rogers H; Schmied V; Son J; Sorenson K; Southcombe F; Webster A; Woodland L; Zwi K, 2025, 'Integrated Health–Social Hubs for Migrant Women and Infants', Pediatrics, 156, pp. S6 - S18, http://dx.doi.org/10.1542/peds.2025-070739A

Rashid MM; Hu N; Khan JR; Chan M; Gray M; Owens L; Jaffe A; Homaira N, 2025, 'The High Burden of Asthma Readmission Among Australian Children: A Population-Based Cohort Study', Respirology, 30, pp. 871 - 881, http://dx.doi.org/10.1111/resp.70049

Ozturk A; Chan M; Khan JR; Hu N; McMullan B; Britton PN; Bartlett A; Kandasamy R; Saravanos GL; Prentice B; Shi T; Jaffe A; Owens L; Homaira N, 2025, 'Clinical Characteristics and In-hospital Outcomes Associated with Respiratory Syncytial Virus vs Other Viral Acute Lower Respiratory Infections in Hospitalized Children Younger Than 2 Years', Journal of Infectious Diseases, 231, pp. 1309 - 1317, http://dx.doi.org/10.1093/infdis/jiae543

Zwi K; Khan JR; Wallace S; van Beek A; Kearns A; Keogh C; Lee A; Rana R; Majidi S; Hu N; Lingam R, 2025, 'Assessing Inequities in Hospital Outcomes for Australian Children From Underserved Populations', Hospital Pediatrics, 15, pp. 423 - 432, http://dx.doi.org/10.1542/hpeds.2024-007902

Awad MM; Forde PM; Girard N; Spicer J; Wang C; Lu S; Mitsudomi T; Felip E; Broderick SR; Swanson SJ; Brahmer J; Kerr K; Saylors GB; Chen K-N; Gharpure V; Neely J; Balli D; Hu N; Pulla MP, 2025, 'Neoadjuvant Nivolumab Plus Ipilimumab Versus Chemotherapy in Resectable Lung Cancer', Journal of Clinical Oncology, 43, pp. 1453 - 1462, http://dx.doi.org/10.1200/jco-24-02239

Singh R; Leung S; Sawrikar V; McHugh C; Hu N; Ardill-Young O; Lingam R; Eapen V; Hodgins M; Curtis J, 2025, 'Increasing Youth Peer Workers' Impact Through Integration: Peer Worker Perspectives on Best Practice in Youth Mental Health', Health Expectations, 28, http://dx.doi.org/10.1111/hex.70223

Miller C; Smithers-Sheedy H; Hu N; Schmidt D; Christie A; Morris T; Sanci L; Lingam R, 2025, 'Reducing Health Inequity for Children and Young People in Rural Australia: Are Digital Interventions a Panacea? A Rural Generalist's Commentary', Australian Journal of Rural Health, 33, http://dx.doi.org/10.1111/ajr.70015

Zwi K; Majidi S; Khan JR; Van Beek A; Kearns A; Rana R; Nobilo A; Vernon B; Hodgins M; Wallace S; Hu N; Lingam R, 2025, 'Providing Enhanced Access to Child Health Services (PEACH) at Sydney Children's Hospital Network: A study protocol', BMJ Open, 15, http://dx.doi.org/10.1136/bmjopen-2024-086107

Khan JR; John JR; Middleton PM; Huang Y; Lin PI; Hu N; Jalaludin B; Chay P; Lingam R; Eapen V, 2025, 'Factors associated with extended length of stay for paediatric mental health presentations to EDs in South Western Sydney, Australia', EMA Emergency Medicine Australasia, 37, http://dx.doi.org/10.1111/1742-6723.70003

Li D; Liu X; Yu J; Zhang Y; Hu N; Lu Y; Sun F; Zhang M; Ma X; Wang F, 2025, 'Item response theory for the color-picture version of Boston naming test in a Chinese sample with neurodegenerative diseases', Journal of Alzheimer S Disease, 103, pp. 775 - 784, http://dx.doi.org/10.1177/13872877241305820

John JR; Khan JR; Middleton PM; Huang Y; Lin PI; Hu N; Jalaludin B; Chay P; Lingam R; Eapen V, 2025, 'Mental health help-seeking behaviours among children and young people from culturally and linguistically diverse communities in a multicultural urban Australian population', Australian and New Zealand Journal of Psychiatry, 59, pp. 171 - 179, http://dx.doi.org/10.1177/00048674241310702

He WQ; Pereira G; Hu N; Lingam R; Hunt L; Gordon A; Jay O; Nassar N, 2025, 'Extreme Heat Stress and Unplanned Hospital Admissions', Pediatrics, 155, http://dx.doi.org/10.1542/peds.2024-068183

Girard N; Lucherini S; Pulla MP; Awad M; Spicer J; Mitsudomi T; Wang C; Lu S; Felip E; Brahmer JR; Broderick S; Ciuleanu T-E; Tanaka F; Saylors G; Lupinacci L; Bhatia S; Cai JL; Hu N; Forde PM, 2025, '126P Neoadjuvant (neoadj) nivolumab (N) + chemotherapy (C) in patients (pts) with resectable NSCLC: Outcomes by subsequent immunotherapy (IO) in CheckMate 816', Immuno-Oncology Technology, 28, pp. 101210, http://dx.doi.org/10.1016/j.iotech.2025.101210

Decaens T; Sangro B; Galle PR; Qin S; Da Fonseca LG; Karachiwala H; Park J-W; Gane E; Pinter M; Tai DWM; Santoro A; Pizarro G; Schenker M; He AR; Hu N; Jimenez MJE; Yau T, 2025, '1486P Nivolumab plus ipilimumab (NIVO + IPI) vs lenvatinib or sorafenib (LEN/SOR) as first-line (1L) treatment for unresectable hepatocellular carcinoma (uHCC): Efficacy in patients (pts) with poor prognosis and hepatic safety in the overall population from CheckMate 9DW', Annals of Oncology, 36, pp. s892 - s893, http://dx.doi.org/10.1016/j.annonc.2025.08.2116

Sangro B; Decaens T; Galle PR; Kudo M; Qin S; Da Fonseca LG; Karachiwala H; Park J-W; Gane E; Pinter M; Tai DWM; Santoro A; Pizarro G; Schenker M; He AR; Hu N; Jimenez MJE; Matteotti R; Blum SI; Yau T, 2025, '148O Overall evaluation of health-related quality of life (HRQoL) and efficacy assessment in patients (pts) who discontinued (d/c) due to treatment-related adverse events (TRAEs): Results from CheckMate 9DW', Annals of Oncology, 36, pp. s62 - s63, http://dx.doi.org/10.1016/j.annonc.2025.05.161

Yau T; Galle PR; Decaens T; Sangro B; Qin S; Park J-W; Ikeda M; Tai D; Chiu C-F; Chon HJ; Kang Y-K; Hiraoka A; Huang Y-H; Lee T-Y; Numata K; Yamashita T; Ogata T; Hu N; Kudo M, 2025, '275MO Overall efficacy outcomes of nivolumab plus ipilimumab by occurrence of immune-mediated adverse events (IMAEs) and additional safety from Asian patients in CheckMate 9DW', Annals of Oncology, 36, pp. s1848, http://dx.doi.org/10.1016/j.annonc.2025.10.102

Shen L; Shitara K; Moehler M; Ajani JA; Garrido M; Liu T; Gallardo C; Wyrwicz LS; Yamaguchi K; Elimova E; Bai Y; Hu N; Lei M; Zhang J; McCraith S; Frantz B; Chen L; Janjigian YY, 2025, '313P Characteristics, treatment patterns, and outcomes with first-line nivolumab plus chemotherapy vs chemotherapy in CheckMate 649 patients by regions', Annals of Oncology, 36, pp. s1861 - s1862, http://dx.doi.org/10.1016/j.annonc.2025.10.140

Yaeger R; Uboha NV; Klempner SJ; Bekaii-Saab TS; Sabari JK; Barve MA; Saltzman JN; Peguero JA; Paulson AS; Jänne PA; Pelster M; Cruz-Correa M; Kim AMK; Hu N; Ahmad HA; Kopetz S, 2025, 'Adagrasib (Ada) + cetuximab (Cetux) for KRASG12C-mutated metastatic colorectal cancer (mCRC): Longer follow-up analysis from KRYSTAL-1.', Journal of Clinical Oncology, 43, pp. 131 - 131, http://dx.doi.org/10.1200/jco.2025.43.4_suppl.131

Shen L; Bai Y; Lin X; Li W; Wang J; Zhang X; Pan H; Bai C; Bai L; Cheng Y; Zhang J; Zhong H; Ba Y; Hu W; Xu R-H; Guo W; Qin S; Hu N; McCraith S; Liu T, 2025, 'First-line (1L) nivolumab (NIVO) plus chemotherapy (chemo) vs chemo in patients (pts) with advanced gastric cancer, gastroesophageal junction cancer, and esophageal adenocarcinoma (GC/GEJC/EAC): 5-year (y) follow-up of Chinese pts from CheckMate 649.', Journal of Clinical Oncology, 43, pp. 392 - 392, http://dx.doi.org/10.1200/jco.2025.43.4_suppl.392

Sangro B; Kudo M; Decaens T; Pinter M; Yau T; Qin S; da Fonseca L; Karachiwala H; Park J-W; Gane EJ; Tai D; Santoro A; Pizarro G; Chiu C-F; Schenker M; He AR; Hu N; Hreiki J; Exposito M-JJ; Galle PR, 2025, 'GS-005 Outcomes by liver function in patients with unresectable hepatocellular carcinoma treated with nivolumab plus ipilimumab vs lenvatinib or sorafenib in the CheckMate 9DWtrial', Journal of Hepatology, 82, pp. s4, http://dx.doi.org/10.1016/s0168-8278(25)00302-2

Janjigian YY; Moehler MH; Ajani JA; Shen L; Garrido M; Gallardo C; Wyrwicz L; Yamaguchi K; Cleary JM; Elimova E; Bruges RE; Karamouzis M; Skoczylas T; Bragagnoli A; Liu T; Tehfe M; McCraith S; Hu N; Zhang J; Shitara K, 2025, 'Nivolumab (NIVO) + chemotherapy (chemo) vs chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): 5-year (y) follow-up results from CheckMate 649.', Journal of Clinical Oncology, 43, pp. 398 - 398, http://dx.doi.org/10.1200/jco.2025.43.4_suppl.398

Kudo M; Yau T; Decaens T; Sangro B; Qin S; Da Fonseca L; Karachiwala H; Park J-W; Gane E; Pinter M; Tai D; Santoro A; Pizarro G; Chiu C-F; Schenker M; He AR; Hu N; Jimenez Exposito MJ; Stromko C; Galle PR, 2025, 'Nivolumab (NIVO) plus ipilimumab (IPI) vs lenvatinib (LEN) or sorafenib (SOR) as first-line (1L) therapy for unresectable hepatocellular carcinoma (uHCC): CheckMate 9DW expanded analyses.', Journal of Clinical Oncology, 43, pp. 520 - 520, http://dx.doi.org/10.1200/jco.2025.43.4_suppl.520

Carbone DP; Ciuleanu T-E; Cobo M; Schenker M; Zurawski B; Menezes J; Richardet E; Felip E; Cheng Y; Juan-Vidal O; Alexandru A; Mizutani H; Reinmuth N; Lu S; Reck M; John T; Scherpereel A; De Marchi P; Aoyama T; Sathyanarayana P; Grootendorst DJ; Hu N; Ip V; Hung Y-H; Paz-Ares LG, 2025, 'Nivolumab plus ipilimumab with chemotherapy as first-line treatment of patients with metastatic non-small-cell lung cancer: final, 6-year outcomes from CheckMate 9LA', ESMO Open, 10, pp. 105123, http://dx.doi.org/10.1016/j.esmoop.2025.105123

Mitsudomi T; Forde PM; Girard N; Provencio M; Awad MM; Wang C; Lu S; Felip E; Broderick SR; Swanson SJ; Brahmer JR; Ciuleanu T-E; Tanaka F; Saylors GS; Chen K-N; Ito H; Liberman M; Martin C; Vokes EE; Wang L; Hu N; Lucherini S; Blum SI; Bhatia S; Spicer JD, 2025, 'OA02.03 Overall Survival (OS) with Neoadjuvant Nivolumab Plus Chemotherapy by Surgical Outcomes in the Phase 3 CheckMate 816 Study', Journal of Thoracic Oncology, 20, pp. s13, http://dx.doi.org/10.1016/j.jtho.2025.09.033

Reck M; Ciuleanu T-E; Schenker M; Bordenave S; Cobo-Dols M; Juan-Vidal O; Reinmuth N; Richardet E; Felip E; Menezes J; Cheng Y; Mizutani H; Carbone DP; Lu S; John T; Aoyama T; Mahmood J; Hu N; Eccles L; Paz-Ares LG, 2025, 'PPD02.01: Five-Year Outcomes with First-Line Nivolumab + Ipilimumab + Chemotherapy Versus Chemotherapy in Patients with Metastatic NSCLC (mNSCLC) in CheckMate 9LA', Journal of Thoracic Oncology, 20, pp. s22 - s23, http://dx.doi.org/10.1016/j.jtho.2025.07.106

John JR; Khan JR; Middleton PM; Huang Y; Lin DPI; Hu N; Jalaludin B; Chay P; Lingam R; Eapen V, 2024, 'Self-harm-related mental health presentations to emergency departments by children and young people from culturally and linguistically diverse groups in South Western Sydney', Bjpsych Open, 10, http://dx.doi.org/10.1192/bjo.2024.763

Cecil E; Forman J; Newham J; Hu N; Lingam R; Wolfe I, 2024, 'Investigating a novel population health management system to increase access to healthcare for children: A nested cross-sectional study within a cluster randomised controlled trial', BMJ Quality and Safety, 33, pp. 694 - 703, http://dx.doi.org/10.1136/bmjqs-2024-017223

Hodgins M; Samir N; Woolfenden S; Hu N; Schneuer F; Nassar N; Lingam R, 2024, 'Alpha NSW: What would it take to create a state-wide paediatric population-level learning health system?', Health Information Management Journal, 53, pp. 217 - 226, http://dx.doi.org/10.1177/18333583231176597

McHugh C; Hu N; Georgiou G; Hodgins M; Leung S; Cadiri M; Paul N; Ryall V; Rickwood D; Eapen V; Curtis J; Lingam R, 2024, 'Integrated care models for youth mental health: A systematic review and meta-analysis', Australian and New Zealand Journal of Psychiatry, 58, pp. 747 - 759, http://dx.doi.org/10.1177/00048674241256759

Mackle R; Gonzalez CC; Chan M; Hodgins M; Hu N; Angell B; Owens L; Fletcher J; McCrossin T; Piper S; Doyle AK; Woolfenden S; Gould B; Ward F; Lingam R; Jaffe A; Gray M; Homaira N; Du H; Haggie S; Flynn A; Bell R; O'Meara M; Crum M; Langstaff C; Molnar K; Zanotti T; Molloy S; Dove C; Hoye A; Reed A; Campbell T; Hutchinson A; Meldrum D; Hodges J; Wilson M; Shaw B; Ratoni T; Petersen S; Greenway K; Carmichael T; Johnston M; Hill S; Saberi E; Behari K; Sweeney S; Moore T; Smeets TI; Eather N; Hunt S; Fryer A; Nichols B; Connors J; De Groot A; Tyler T; Leccese K; Harrison P; Mitchell A; Bonal M; Singh R; Smith D; Hale M; Lloyd C; White JA; Geale L; Hankinson J; Eddie S; Fisher K; Buck G; Tozer A; King F; Vartiainen A; Archer K; Howard D; Williams L; Fitzgerald D; Sgarlata J; Berry M; Edwards R; Streat K; Mannix P; Cole K; Reedy G; Hayes K; De Keizer S; McNamara P, 2024, 'Asthma Care from Home: Study protocol for an effectiveness-implementation evaluation of a virtually enabled asthma care initiative in children in rural NSW', Plos One, 19, http://dx.doi.org/10.1371/journal.pone.0304711

Lingam R; Hu N; Cecil E; Forman J; Newham J; Satherley RM; Bori MS; Cousens S; Fox-Rushby J; Wolfe I, 2024, 'Changing contexts of child health: An assessment of unmet physical, psychological and social needs of children with common chronic childhood illness', Archives of Disease in Childhood, 109, pp. 488 - 496, http://dx.doi.org/10.1136/archdischild-2023-326766

Reck M; Ciuleanu T-E; Schenker M; Bordenave S; Cobo M; Juan-Vidal O; Reinmuth N; Richardet E; Felip E; Menezes J; Cheng Y; Mizutani H; Carbone DP; Lu S; John T; Aoyama T; Mahmood J; Hu N; Eccles L; Paz-Ares LG, 2024, 'Five-year outcomes with first-line (1L) nivolumab + ipilimumab + chemotherapy (N + I + C) vs C in patients (pts) with metastatic NSCLC (mNSCLC) in CheckMate 9LA.', Journal of Clinical Oncology, 42, pp. 8560 - 8560, http://dx.doi.org/10.1200/jco.2024.42.16_suppl.8560

Back to profile page